Comparison of ZFNs versus CRISPR specific nucleases for genome edition of the Wiskott-Aldrich Syndrome locus

被引：0
|
作者：
Sanchez-Hernandez, S. [1 ]
Gutierrez-Guerrero, A. [1 ]
Galvani, G. [1 ]
Pinedo-Gomez, J. [1 ]
Cobo, M. [1 ]
Martin, R. [1 ]
Aguilar-Gonzalez, A. [1 ]
Gregory, P. D. [2 ]
Holmes, M. C. [2 ]
Benabdellah, K. [1 ]
Martin, F. [1 ]
机构：
[1] Pfizer Univ Granada Junta Andalucia, GENyO Ctr Genom & Invest Oncol, Granada, Spain
[2] Sangamo BioSci Inc, Richmond, CA USA
来源：
HUMAN GENE THERAPY | 2017年 / 28卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P150
引用
收藏
页码：A59 / A59
页数：1
相关论文
共 44 条
  • [1] Comparison of Zinc Finger Nucleases Versus CRISPR-Specific Nucleases for Genome Editing of the Wiskott-Aldrich Syndrome Locus
    Gutierrez-Guerrero, Alejandra
    Sanchez-Hernandez, Sabina
    Galvani, Giuseppe
    Pinedo-Gomez, Javier
    Martin-Guerra, Rocio
    Sanchez-Gilabert, Almudena
    Aguilar-Gonzalez, Araceli
    Cobo, Marien
    Gregory, Philip
    Holmes, Michael
    Benabdellah, Karim
    Martin, Francisco
    HUMAN GENE THERAPY, 2018, 29 (03) : 366 - 380
  • [2] Gene Edition for Wiskott-Aldrich Syndrome Gene Therapy
    Martin, Francisco
    Munoz, Pilar
    Cobo, Marien
    Sanchez-Gilabert, Almudena
    Real, Pedro
    Ramos, Veronica
    Gregory, Philip D.
    Holmes, Michael C.
    Toscano, Miguel G.
    MOLECULAR THERAPY, 2015, 23 : S136 - S136
  • [3] Comparison of genome editing tools for Wiskott-Aldrich syndrome gene therapy
    Gutierrez-Guerreo, A.
    Sanchez-Hernandez, S.
    Galvani, G.
    Pinedo-Gomez, J.
    Toscano, M. G.
    Cobo, M.
    Gregory, P. D.
    Holmes, M. C.
    Benabdellah, K.
    Martin, F.
    HUMAN GENE THERAPY, 2016, 27 (11) : A130 - A131
  • [4] CRISPR Cas9-Mediated Genome Editing for the Modelling and Correction of Wiskott-Aldrich Syndrome
    Thangavel, Saravanabhavan
    MOLECULAR THERAPY, 2018, 26 (05) : 240 - 241
  • [5] Improving gene edition tools for Wiskott-Aldrich Syndrome gene therapy
    Gutierrez-Guerrero, Alejandra
    Sanchez-Hernandez, Sabina
    Galvani, Giuseppe
    Martin, Francisco
    Benabdellah, Karim
    HUMAN GENE THERAPY, 2014, 25 (11) : A66 - A66
  • [6] Genome editing for primary immunodeficiencies: A therapeutic perspective on Wiskott-Aldrich syndrome
    Naseem, Asma
    Steinberg, Zohar
    Cavazza, Alessia
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [7] Improving gene edition tools for Wiskott-Aldrich Syndrome gene therapy.
    Gutierrez-Guerrero, A.
    Sanchez-Hernandez, S.
    Galvani, G.
    Toscano, M. G.
    Cobo, M.
    Gregory, P. D.
    Holmes, M. C.
    Benabdellah, K.
    Martin, F.
    HUMAN GENE THERAPY, 2015, 26 (10) : A51 - A51
  • [8] CRISPR/Cas9-mediated gene editing for treatment of the Wiskott-Aldrich Syndrome
    Pille, M.
    Avila, J. M.
    Park, S. H.
    Xue, H.
    Haerynck, F.
    Kerre, T.
    Bao, G.
    Vandekerckhove, B.
    Davis, B. R.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A62 - A63
  • [9] Genome editing: An alternative to retroviral vectors for Wiskott-Aldrich Syndrome (WAS) Gene Therapy?
    Martin, F.
    Gutierrez-Guerrero, A.
    Sanchez, S.
    Galvani, G.
    Benabdellah, K.
    EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (03): : 281 - 289
  • [10] YAC MAPPING OF THE WISKOTT-ALDRICH SYNDROME LOCUS IN XP11.31-]P11.22
    KWAN, SP
    HAGEMANN, T
    GUAN, L
    ROSEN, FS
    MONACO, AP
    LEHRACH, H
    CYTOGENETICS AND CELL GENETICS, 1993, 64 (3-4): : 181 - 181
12345